{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,25]],"date-time":"2026-06-25T04:38:07Z","timestamp":1782362287068,"version":"3.54.5"},"reference-count":64,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2019,10,1]],"date-time":"2019-10-01T00:00:00Z","timestamp":1569888000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,10,1]],"date-time":"2019-10-01T00:00:00Z","timestamp":1569888000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","theclinics.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Dermatologic Clinics"],"published-print":{"date-parts":[[2019,10]]},"DOI":"10.1016\/j.det.2019.05.011","type":"journal-article","created":{"date-parts":[[2019,7,10]],"date-time":"2019-07-10T00:41:18Z","timestamp":1562719278000},"page":"537-544","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"title":["Dermatology in the Diagnosis of Noncutaneous Malignancy"],"prefix":"10.1016","volume":"37","author":[{"given":"Jesse J.","family":"Keller","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicole M.","family":"Fett","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lynne H.","family":"Morrison","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.det.2019.05.011_bib1","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1177\/1203475417690719","article-title":"Sweet syndrome: clinical features, histopathology, and associations of 83 cases","volume":"21","author":"Casarin Costa","year":"2017","journal-title":"J\u00a0Cutan Med Surg"},{"issue":"6","key":"10.1016\/j.det.2019.05.011_bib2","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1016\/j.clml.2014.12.009","article-title":"Characteristics of Sweet syndrome in patients with acute myeloid leukemia","volume":"15","author":"Kazmi","year":"2015","journal-title":"Clin Lymphoma Myeloma Leuk"},{"key":"10.1016\/j.det.2019.05.011_bib3","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1056\/NEJM199202063260602","article-title":"Risk of cancer in patients with dermatomyositis or polymyositis. A population-based study","volume":"326","author":"Sigurgeirsson","year":"1992","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.det.2019.05.011_bib4","doi-asserted-by":"crossref","first-page":"1087","DOI":"10.7326\/0003-4819-134-12-200106190-00008","article-title":"Incidence of malignant disease in biopsy-proven inflammatory myopathy. A population-based cohort study","volume":"134","author":"Buchbinder","year":"2001","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.det.2019.05.011_bib5","doi-asserted-by":"crossref","first-page":"R70","DOI":"10.1186\/ar2987","article-title":"Cancer risks of\u00a0dermatomyositis and polymyositis: a nationwide cohort study in Taiwan","volume":"12","author":"Chen","year":"2010","journal-title":"Arthritis Res Ther"},{"key":"10.1016\/j.det.2019.05.011_bib6","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1007\/s40257-015-0120-1","article-title":"Cancer risk in dermatomyositis: a meta-analysis of cohort studies","volume":"16","author":"Olazagasti","year":"2015","journal-title":"Am J Clin Dermatol"},{"key":"10.1016\/j.det.2019.05.011_bib7","doi-asserted-by":"crossref","first-page":"282","DOI":"10.3899\/jrheum.140566","article-title":"Polymyositis\/dermatomyositis and malignancy risk: a metaanalysis study","volume":"42","author":"Yang","year":"2015","journal-title":"J\u00a0Rheumatol"},{"key":"10.1016\/j.det.2019.05.011_bib8","doi-asserted-by":"crossref","first-page":"838","DOI":"10.1111\/bjd.12564","article-title":"Meta-analysis of the association of dermatomyositis and polymyositis with cancer","volume":"169","author":"Wang","year":"2013","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.det.2019.05.011_bib9","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1002\/art.33379","article-title":"Usefulness of anti-p155 autoantibody for diagnosing cancer-associated dermatomyositis: a systematic review and meta-analysis","volume":"64","author":"Trallero-Araguas","year":"2012","journal-title":"Arthritis Rheum"},{"issue":"6","key":"10.1016\/j.det.2019.05.011_bib10","first-page":"990","article-title":"Strong correlation between cancer progression and anti-transcription intermediary factor 1gamma antibodies in dermatomyositis patients","volume":"36","author":"Ogawa-Momohara","year":"2018","journal-title":"Clin Exp Rheumatol"},{"key":"10.1016\/j.det.2019.05.011_bib11","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1093\/rheumatology\/kex413","article-title":"Tumour TIF1 mutations and loss of heterozygosity related to cancer-associated myositis","volume":"57","author":"Pinal-Fernandez","year":"2018","journal-title":"Rheumatology"},{"key":"10.1016\/j.det.2019.05.011_bib12","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1136\/annrheumdis-2011-200697","article-title":"Anti-NXP2 autoantibodies in adult patients with idiopathic inflammatory myopathies: possible association with malignancy","volume":"71","author":"Ichimura","year":"2012","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.det.2019.05.011_bib13","doi-asserted-by":"crossref","first-page":"1909","DOI":"10.1002\/acr.23210","article-title":"Cutaneous and systemic findings associated with nuclear matrix protein 2 antibodies in adult dermatomyositis patients","volume":"69","author":"Rogers","year":"2017","journal-title":"Arthritis Care Res"},{"key":"10.1016\/j.det.2019.05.011_bib14","doi-asserted-by":"crossref","first-page":"2954","DOI":"10.1002\/art.38093","article-title":"Most patients with cancer-associated dermatomyositis have antibodies to nuclear matrix protein NXP-2 or transcription intermediary factor 1gamma","volume":"65","author":"Fiorentino","year":"2013","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.det.2019.05.011_bib15","doi-asserted-by":"crossref","first-page":"835","DOI":"10.3899\/jrheum.170544","article-title":"Increased levels of soluble programmed death ligand 1 associate with malignancy in patients with dermatomyositis","volume":"45","author":"Chen","year":"2018","journal-title":"J\u00a0Rheumatol"},{"key":"10.1016\/j.det.2019.05.011_bib16","doi-asserted-by":"crossref","DOI":"10.1097\/BOR.0000000000000535","article-title":"The diagnostic work-up of cancer-associated myositis","author":"Selva-O'Callaghan","year":"2018","journal-title":"Curr Opin Rheumatol"},{"key":"10.1016\/j.det.2019.05.011_bib17","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1001\/archderm.138.7.885","article-title":"Routine vs extensive malignancy search for adult dermatomyositis and polymyositis: a study of 40 patients","volume":"138","author":"Sparsa","year":"2002","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.det.2019.05.011_bib18","doi-asserted-by":"crossref","first-page":"e9639","DOI":"10.1097\/MD.0000000000009639","article-title":"Evidence supports blind screening for internal malignancy in dermatomyositis: data from 2 large US dermatology cohorts","volume":"97","author":"Leatham","year":"2018","journal-title":"Medicine"},{"key":"10.1016\/j.det.2019.05.011_bib19","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1016\/j.amjmed.2009.11.012","article-title":"Conventional cancer screening versus PET\/CT in dermatomyositis\/polymyositis","volume":"123","author":"Selva-O'Callaghan","year":"2010","journal-title":"Am J Med"},{"key":"10.1016\/j.det.2019.05.011_bib20","doi-asserted-by":"crossref","first-page":"e0181069","DOI":"10.1371\/journal.pone.0181069","article-title":"An efficacy analysis of whole-body magnetic resonance imaging in the diagnosis and follow-up of polymyositis and dermatomyositis","volume":"12","author":"Huang","year":"2017","journal-title":"PLoS One"},{"key":"10.1016\/j.det.2019.05.011_bib21","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1046\/j.1365-2133.2002.04992.x","article-title":"Paraneoplastic pemphigus in children and adolescents","volume":"147","author":"Mimouni","year":"2002","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.det.2019.05.011_bib22","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1111\/j.1087-0024.2004.00832.x","article-title":"Paraneoplastic pemphigus","volume":"9","author":"Anhalt","year":"2004","journal-title":"J\u00a0Investig Dermatol Symp Proc"},{"key":"10.1016\/j.det.2019.05.011_bib23","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1111\/j.1440-1843.2008.01397.x","article-title":"Constrictive bronchiolitis associated with paraneoplastic autoimmune multi-organ syndrome","volume":"14","author":"Maldonado","year":"2009","journal-title":"Respirology"},{"key":"10.1016\/j.det.2019.05.011_bib24","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1111\/j.1365-4632.2011.04868.x","article-title":"Paraneoplastic autoimmune multi-organ syndrome: 20 years after","volume":"50","author":"Czernik","year":"2011","journal-title":"Int J Dermatol"},{"key":"10.1016\/j.det.2019.05.011_bib25","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.1001\/archdermatol.2012.1830","article-title":"Prognostic factors of paraneoplastic pemphigus","volume":"148","author":"Leger","year":"2012","journal-title":"Arch Dermatol"},{"issue":"4","key":"10.1016\/j.det.2019.05.011_bib26","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1016\/j.jaad.2006.04.047","article-title":"Acquired ichthyosis","volume":"55","author":"Patel","year":"2006","journal-title":"J\u00a0Am Acad Dermatol"},{"key":"10.1016\/j.det.2019.05.011_bib27","doi-asserted-by":"crossref","first-page":"1446","DOI":"10.1001\/archderm.1975.01630230048008","article-title":"Acquired ichthyosis\u2014a sign of nonlymphoproliferative malignant disorders","volume":"111","author":"Flint","year":"1975","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.det.2019.05.011_bib28","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1016\/S1470-2045(02)00928-2","article-title":"Acquired ichthyosis: a paraneoplastic skin manifestation of Hodgkin's disease","volume":"3","author":"Rizos","year":"2002","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.det.2019.05.011_bib29","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1046\/j.1365-2230.2001.00791.x","article-title":"Hypertrichosis lanuginosa acquisita preceding extraskeletal Ewing\u2019s sarcoma","volume":"26","author":"Perez-Losada","year":"2001","journal-title":"Clin Exp Dermatol"},{"key":"10.1016\/j.det.2019.05.011_bib30","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1002\/(SICI)1096-9098(199807)68:3<199::AID-JSO13>3.0.CO;2-X","article-title":"Acquired hypertrichosis lanuginosa: case report and review of the literature","volume":"68","author":"Farina","year":"1998","journal-title":"J\u00a0Surg Oncol"},{"key":"10.1016\/j.det.2019.05.011_bib31","doi-asserted-by":"crossref","first-page":"2013","DOI":"10.1001\/archinte.1987.00370110141021","article-title":"Acquired hypertrichosis lanuginosa associated with malignancy","volume":"147","author":"Hovenden","year":"1987","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.det.2019.05.011_bib32","first-page":"6834","article-title":"Skin disorders as markers of internal disease: paraneoplastic dermatoses","volume":"162","author":"Weismann","year":"2000","journal-title":"Ugeskr Laeger"},{"key":"10.1016\/j.det.2019.05.011_bib33","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1055\/s-2001-16016","article-title":"Circumscribed hypertrichosis lanuginosa in acute myeloid leukemia","volume":"126","author":"Bauer","year":"2001","journal-title":"Dtsch Med Wochenschr"},{"key":"10.1016\/j.det.2019.05.011_bib34","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1067\/mjd.2003.100","article-title":"Hypertrichosis","volume":"48","author":"Wendelin","year":"2003","journal-title":"J\u00a0Am Acad Dermatol"},{"issue":"5","key":"10.1016\/j.det.2019.05.011_bib35","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1016\/0190-9622(92)70107-Q","article-title":"Erythema gyratum repens: a paraneoplastic eruption","volume":"26","author":"Boyd","year":"1992","journal-title":"J\u00a0Am Acad Dermatol"},{"issue":"7","key":"10.1016\/j.det.2019.05.011_bib36","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1111\/jdv.14199","article-title":"Acrokeratosis paraneoplastica (Bazex syndrome)\u2014a systematic review on risk factors, diagnosis, prognosis and management","volume":"31","author":"RaBler","year":"2017","journal-title":"J\u00a0Eur Acad Dermatol Venereol"},{"key":"10.1016\/j.det.2019.05.011_bib37","doi-asserted-by":"crossref","first-page":"485","DOI":"10.2298\/VSP0806485M","article-title":"Acrokeratosis paraneoplastica Bazex syndrome associated with esophageal squamocellular carcinoma","volume":"65","author":"Medenica","year":"2008","journal-title":"Vojnosanit Pregl"},{"key":"10.1016\/j.det.2019.05.011_bib38","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1111\/j.1529-8019.2010.01371.x","article-title":"Diagnosis and treatment of cutaneous paraneoplastic disorders","volume":"23","author":"Abreu Velez","year":"2010","journal-title":"Dermatol Ther"},{"key":"10.1016\/j.det.2019.05.011_bib39","first-page":"481","article-title":"Skin lesions in a patient with head and neck cancer","volume":"71","author":"Driessen","year":"2013","journal-title":"Neth J Med"},{"key":"10.1016\/j.det.2019.05.011_bib40","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1111\/j.1365-2133.1986.tb05770.x","article-title":"Bazex paraneoplastic acrokeratosis: a case report and response to Tigason","volume":"115","author":"Wishart","year":"1986","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.det.2019.05.011_bib41","first-page":"26","article-title":"Bazex paraneoplastic acrokeratosis. Treatment with acitretin","volume":"122","author":"Esteve","year":"1995","journal-title":"Ann Dermatol Venereol"},{"key":"10.1016\/j.det.2019.05.011_bib42","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1046\/j.1440-0960.2001.00535.x","article-title":"Bullous lesions in Bazex syndrome and successful treatment with oral psoralen phototherapy","volume":"42","author":"Gill","year":"2001","journal-title":"Australas J Dermatol"},{"key":"10.1016\/j.det.2019.05.011_bib43","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1186\/1471-2490-14-88","article-title":"Malignant acanthosis nigricans associated with prostate cancer: a case report","volume":"14","author":"Kubicka-Wolkowska","year":"2014","journal-title":"BMC Urol"},{"key":"10.1016\/j.det.2019.05.011_bib44","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1111\/j.1524-4725.1980.tb01003.x","article-title":"Malignant acanthosis nigricans: a review","volume":"11","author":"Rigel","year":"1980","journal-title":"J\u00a0Dermatol Surg Oncol"},{"key":"10.1016\/j.det.2019.05.011_bib45","first-page":"254","article-title":"Paraneoplastic type of acanthosis nigricans in patient with hepatocellular carcinoma","volume":"52","author":"Kami\u0144ska-Winciorek","year":"2007","journal-title":"Adv Med Sci"},{"key":"10.1016\/j.det.2019.05.011_bib46","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1007\/s001050050699","article-title":"Acanthosis nigricans maligna. Case report and review of the literature","volume":"49","author":"Lenzner","year":"1998","journal-title":"Hautarzt"},{"key":"10.1016\/j.det.2019.05.011_bib47","doi-asserted-by":"crossref","first-page":"1582","DOI":"10.1056\/NEJM198712173172506","article-title":"Melanoma, growth factors, acanthosis nigricans, the sign of Leser-Trelat, and multiple acrochordons. A possible role for alpha-transforming growth factor in cutaneous paraneoplastic syndromes","volume":"317","author":"Ellis","year":"1987","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.det.2019.05.011_bib48","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1007\/BF01213299","article-title":"Transforming growth factor alpha (TGF-alpha)-producing gastric carcinoma with acanthosis nigricans: an endocrine effect of TGF-alpha in the pathogenesis of cutaneous paraneoplastic syndrome and epithelial hyperplasia of the esophagus","volume":"32","author":"Koyama","year":"1997","journal-title":"J\u00a0Gastroenterol"},{"key":"10.1016\/j.det.2019.05.011_bib49","doi-asserted-by":"crossref","first-page":"1096","DOI":"10.1046\/j.1365-2133.2002.05150.x","article-title":"Genes, growth factors and acanthosis nigricans","volume":"147","author":"Torley","year":"2002","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.det.2019.05.011_bib50","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1007\/BF00372579","article-title":"Further evidence that acanthosis nigricans maligna is linked to enhanced secretion by the tumour of transforming growth factor alpha","volume":"284","author":"Wilgenbus","year":"1992","journal-title":"Arch Dermatol Res"},{"key":"10.1016\/j.det.2019.05.011_bib51","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1016\/j.jaad.2004.06.051","article-title":"Clinical and pathologic findings of paraneoplastic dermatoses","volume":"54","author":"Chung","year":"2006","journal-title":"J\u00a0Am Acad Dermatol"},{"key":"10.1016\/j.det.2019.05.011_bib52","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1530\/eje.0.1510531","article-title":"The glucagonoma syndrome and necrolytic migratory erythema: a clinical review","volume":"151","author":"van Beek","year":"2004","journal-title":"Eur J Endocrinol"},{"issue":"5","key":"10.1016\/j.det.2019.05.011_bib53","first-page":"e1","article-title":"Necrolytic migratory erythema: a common cutaneous clue of uncommon syndromes","volume":"92","author":"Stavropoulos","year":"2013","journal-title":"Cutis"},{"key":"10.1016\/j.det.2019.05.011_bib54","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1097\/00000441-200105000-00003","article-title":"The glucagonoma syndrome: a review of its features and discussion of new perspectives","volume":"321","author":"Chastain","year":"2001","journal-title":"Am J Med Sci"},{"key":"10.1016\/j.det.2019.05.011_bib55","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0140-6736(74)91343-9","article-title":"A\u00a0glucagonoma syndrome","volume":"6","author":"Mallinson","year":"1974","journal-title":"Lancet"},{"issue":"12","key":"10.1016\/j.det.2019.05.011_bib56","doi-asserted-by":"crossref","first-page":"2016","DOI":"10.1111\/jdv.13752","article-title":"Glucagonoma syndrome: a review and update on treatment","volume":"30","author":"John","year":"2016","journal-title":"J\u00a0Eur Acad Dermatol Venereol"},{"issue":"3","key":"10.1016\/j.det.2019.05.011_bib57","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/S0001-7310(05)73062-3","article-title":"Necrolytic migratory erythema associated with glucagonoma","volume":"96","author":"Mendoza-Guil","year":"2005","journal-title":"Actas Dermosifiliogr"},{"issue":"4","key":"10.1016\/j.det.2019.05.011_bib58","article-title":"Necrolytic migratory erythema associated with glucagonoma treated successfully with cyclosporine","volume":"30","author":"Jimenez-Gall","year":"2017","journal-title":"Dermatol Ther"},{"issue":"3","key":"10.1016\/j.det.2019.05.011_bib59","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1001\/jamadermatol.2015.3538","article-title":"Rapid clearance of necrolytic migratory erythema following intravenous administration of amino acids","volume":"152","author":"Thomaidou","year":"2016","journal-title":"JAMA Dermatol"},{"issue":"3","key":"10.1016\/j.det.2019.05.011_bib60","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1007\/s12328-014-0471-9","article-title":"Rapid improvement of glucagonoma-related necrolytic migratory erythema with octreotide","volume":"7","author":"Kimbara","year":"2014","journal-title":"Clin J Gastroenterol"},{"issue":"2","key":"10.1016\/j.det.2019.05.011_bib61","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1093\/qjmed\/hct027","article-title":"Glucagonoma with necrolytic migratory erythema exhibiting responsiveness to subcutaneous octreotide injections","volume":"107","author":"Lo","year":"2014","journal-title":"QJM"},{"issue":"2","key":"10.1016\/j.det.2019.05.011_bib62","doi-asserted-by":"crossref","first-page":"e44","DOI":"10.1016\/j.jaad.2012.04.030","article-title":"Octreotide-responsive necrolytic migratory erythema in a patient with pseudoglucagonoma syndrome","volume":"68","author":"Virani","year":"2013","journal-title":"J\u00a0Am Acad Dermatol"},{"issue":"6","key":"10.1016\/j.det.2019.05.011_bib63","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1007\/s11926-015-0511-6","article-title":"Multicentric reticulohistiocytosis: a critical review","volume":"17","author":"Selmi","year":"2015","journal-title":"Curr Rheumatol Rep"},{"issue":"1","key":"10.1016\/j.det.2019.05.011_bib64","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/j.hoc.2017.09.010","article-title":"POEMS syndrome: diagnosis and investigative work-up","volume":"32","author":"Dispenzieri","year":"2018","journal-title":"Hematol Oncol Clin North Am"}],"container-title":["Dermatologic Clinics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0733863519300531?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0733863519300531?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T10:45:05Z","timestamp":1760006705000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0733863519300531"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,10]]},"references-count":64,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2019,10]]}},"alternative-id":["S0733863519300531"],"URL":"https:\/\/doi.org\/10.1016\/j.det.2019.05.011","relation":{},"ISSN":["0733-8635"],"issn-type":[{"value":"0733-8635","type":"print"}],"subject":[],"published":{"date-parts":[[2019,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Dermatology in the Diagnosis of Noncutaneous Malignancy","name":"articletitle","label":"Article Title"},{"value":"Dermatologic Clinics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.det.2019.05.011","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}